Paths to stemness: building the ultimate antitumour t cell

KEY POINTS * T lymphocytes transition through progressive stages of differentiation that are characterized by a stepwise loss of functional and therapeutic potential. * Subsets of mature T

cells exhibit the stem cell-like attributes of self-renewal, multipotency and the ability to undergo asymmetric division. * Evolutionarily conserved pathways regulating stemness are active

in T cells, including T memory stem cells, T helper 17 cells and interleukin-17 (IL-17)-producing CD8+ T cells. * Pharmacological and genetic induction of stem cell pathways can be used to

generate tumour-specific T cells with stem cell-like properties. * Reprogramming terminally differentiated tumour-reactive T cells to display naive or stem cell-like functionalities might be

obtained through the expression of transcription factors or microRNAs that are associated with naive or T memory stem cells. * Stem cell-like T cells possess enhanced capacities to engraft,

persist and mediate prolonged immune attack against tumour masses that are sustained by long-lived cancer stem cells. ABSTRACT Stem cells are defined by the ability to self-renew and to

generate differentiated progeny, qualities that are maintained by evolutionarily conserved pathways that can lead to cancer when deregulated. There is now evidence that these stem cell-like

attributes and signalling pathways are also shared among subsets of mature memory T lymphocytes. We discuss how using stem cell-like T cells can overcome the limitations of current adoptive

T cell therapies, including inefficient T cell engraftment, persistence and ability to mediate prolonged immune attack. Conferring stemness to antitumour T cells might unleash the full

potential of cellular therapies. Access through your institution Buy or subscribe This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your

institution Subscribe to this journal Receive 12 print issues and online access $209.00 per year only $17.42 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access

to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read

our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS STEM-LIKE EXHAUSTED AND MEMORY CD8+ T CELLS IN CANCER Article 11 October 2023 CELLULAR NETWORKS CONTROLLING T CELL

PERSISTENCE IN ADOPTIVE CELL THERAPY Article 20 April 2021 T CELL DYSFUNCTION AND THERAPEUTIC INTERVENTION IN CANCER Article 18 July 2024 REFERENCES * Weissman, I. L. Stem cells: units of

development, units of regeneration, and units in evolution. _Cell_ 100, 157–168 (2000). Article  CAS  PubMed  Google Scholar  * Spangrude, G. J., Heimfeld, S. & Weissman, I. L.

Purification and characterization of mouse hematopoietic stem cells. _Science_ 241, 58–62 (1988). Article  CAS  PubMed  Google Scholar  * Reynolds, B. A. & Weiss, S. Generation of

neurons and astrocytes from isolated cells of the adult mammalian central nervous system. _Science_ 255, 1707–1710 (1992). Article  CAS  PubMed  Google Scholar  * Barker, N. et al.

Identification of stem cells in small intestine and colon by marker gene Lgr5. _Nature_ 449, 1003–1007 (2007). Article  CAS  PubMed  Google Scholar  * Sun, T. T. & Green, H.

Differentiation of the epidermal keratinocyte in cell culture: formation of the cornified envelope. _Cell_ 9, 511–521 (1976). Article  CAS  PubMed  Google Scholar  * Beltrami, A. P. et al.

Adult cardiac stem cells are multipotent and support myocardial regeneration. _Cell_ 114, 763–776 (2003). Article  CAS  PubMed  Google Scholar  * Rawlins, E. L. et al. The role of Scgb1a1+

Clara cells in the long-term maintenance and repair of lung airway, but not alveolar, epithelium. _Cell Stem Cell_ 4, 525–534 (2009). Article  CAS  PubMed  PubMed Central  Google Scholar  *

Reya, T., Morrison, S. J., Clarke, M. F. & Weissman, I. L. Stem cells, cancer, and cancer stem cells. _Nature_ 414, 105–111 (2001). Article  CAS  PubMed  Google Scholar  * Nguyen, L. V.,

Vanner, R., Dirks, P. & Eaves, C. J. Cancer stem cells: an evolving concept. _Nature Rev. Cancer_ 12, 133–143 (2012). Article  CAS  PubMed  Google Scholar  * Kaech, S. M., Wherry, E. J.

& Ahmed, R. Effector and memory T-cell differentiation: implications for vaccine development. _Nature Rev. Immunol._ 2, 251–262 (2002). Article  CAS  Google Scholar  * Sallusto, F.,

Geginat, J. & Lanzavecchia, A. Central memory and effector memory T cell subsets: function, generation, and maintenance. _Annu. Rev. Immunol._ 22, 745–763 (2004). Article  CAS  PubMed 

Google Scholar  * Klebanoff, C. A., Gattinoni, L. & Restifo, N. P. CD8+ T-cell memory in tumor immunology and immunotherapy. _Immunol. Rev._ 211, 214–224 (2006). Article  CAS  PubMed 

PubMed Central  Google Scholar  * Gett, A. V., Sallusto, F., Lanzavecchia, A. & Geginat, J. T cell fitness determined by signal strength. _Nature Immunol._ 4, 355–360 (2003). Article 

CAS  Google Scholar  * D'Souza, W. N. & Hedrick, S. M. Cutting edge: latecomer CD8 T cells are imprinted with a unique differentiation program. _J. Immunol._ 177, 777–781 (2006).

Article  CAS  PubMed  Google Scholar  * Sarkar, S. et al. Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates. _J. Exp. Med._ 205, 625–640 (2008).

Article  CAS  PubMed  PubMed Central  Google Scholar  * Chattopadhyay, P. K. et al. Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry. _Nature

Med._ 12, 972–977 (2006). Article  CAS  PubMed  Google Scholar  * Newell, E. W., Sigal, N., Bendall, S. C., Nolan, G. P. & Davis, M. M. Cytometry by time-of-flight shows combinatorial

cytokine expression and virus-specific cell niches within a continuum of CD8+ T cell phenotypes. _Immunity_ 36, 142–152 (2012). Article  CAS  PubMed  PubMed Central  Google Scholar  * Ahmed,

R., Bevan, M. J., Reiner, S. L. & Fearon, D. T. The precursors of memory: models and controversies. _Nature Rev. Immunol._ 9, 662–668 (2009). Article  CAS  Google Scholar  * Gattinoni,

L. et al. A human memory T cell subset with stem cell-like properties. _Nature Med._ 17, 1290–1297 (2011). THIS PAPER IDENTIFIES A NEW SUBSET OF MEMORY T CELLS WITH ENHANCED STEM CELL-LIKE

PROPERTIES IN HUMANS AND SHOWS THAT THESE CELLS MEDIATE A SUPERIOR ANTITUMOUR RESPONSE IN A MOUSE MODEL OF ADOPTIVE T CELL THERAPY. Article  CAS  PubMed  Google Scholar  * De Rosa, S. C.,

Herzenberg, L. A., Herzenberg, L. A. & Roederer, M. 11-color, 13-parameter flow cytometry: identification of human naive T cells by phenotype, function, and T-cell receptor diversity.

_Nature Med._ 7, 245–248 (2001). Article  CAS  PubMed  Google Scholar  * Weninger, W., Crowley, M. A., Manjunath, N. & von Andrian, U. H. Migratory properties of naive, effector, and

memory CD8+ T cells. _J. Exp. Med._ 194, 953–966 (2001). Article  CAS  PubMed  PubMed Central  Google Scholar  * Oberdoerffer, S. et al. Regulation of CD45 alternative splicing by

heterogeneous ribonucleoprotein, hnRNPLL. _Science_ 321, 686–691 (2008). Article  CAS  PubMed  PubMed Central  Google Scholar  * Wu, Z. et al. Memory T cell RNA rearrangement programmed by

heterogeneous nuclear ribonucleoprotein hnRNPLL. _Immunity_ 29, 863–875 (2008). Article  CAS  PubMed  PubMed Central  Google Scholar  * Sallusto, F., Lenig, D., Forster, R., Lipp, M. &

Lanzavecchia, A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. _Nature_ 401, 708–712 (1999). Article  CAS  PubMed  Google Scholar  * Henson, S.

M. et al. KLRG1 signaling induces defective Akt (ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8+ T cells. _Blood_ 113, 6619–6628 (2009). Article  CAS 

PubMed  Google Scholar  * Romero, P. et al. Four functionally distinct populations of human effector-memory CD8+ T lymphocytes. _J. Immunol._ 178, 4112–4119 (2007). Article  CAS  PubMed 

Google Scholar  * Kambayashi, T., Assarsson, E., Lukacher, A. E., Ljunggren, H. G. & Jensen, P. E. Memory CD8+ T cells provide an early source of IFN-γ. _J. Immunol._ 170, 2399–2408

(2003). Article  CAS  PubMed  Google Scholar  * Judge, A. D., Zhang, X., Fujii, H., Surh, C. D. & Sprent, J. Interleukin 15 controls both proliferation and survival of a subset of

memory-phenotype CD8+ T cells. _J. Exp. Med._ 196, 935–946 (2002). Article  CAS  PubMed  PubMed Central  Google Scholar  * Tan, J. T. et al. Interleukin (IL)-15 and IL-7 jointly regulate

homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. _J. Exp. Med._ 195, 1523–1532 (2002). Article  CAS  PubMed  PubMed Central 

Google Scholar  * Hamann, D. et al. Phenotypic and functional separation of memory and effector human CD8+ T cells. _J. Exp. Med._ 186, 1407–1418 (1997). Article  CAS  PubMed  PubMed Central

  Google Scholar  * Siegel, R. M., Chan, F. K., Chun, H. J. & Lenardo, M. J. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. _Nature Immunol._ 1,

469–474 (2000). Article  CAS  Google Scholar  * Stadler, B. M. & Ruohola-Baker, H. Small RNAs: keeping stem cells in line. _Cell_ 132, 563–566 (2008). Article  CAS  PubMed  PubMed

Central  Google Scholar  * Ma, F. et al. The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ. _Nature Immunol._

12, 861–869 (2011). Article  CAS  Google Scholar  * Steiner, D. F. et al. MicroRNA-29 regulates T-box transcription factors and interferon-γ production in helper T cells. _Immunity_ 35,

169–181 (2011). Article  CAS  PubMed  PubMed Central  Google Scholar  * O'Connell, R. M. et al. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell

development. _Immunity_ 33, 607–619 (2010). Article  CAS  PubMed  PubMed Central  Google Scholar  * Wu, H. et al. miRNA profiling of naive, effector and memory CD8 T cells. _PLoS ONE._ 2,

e1020 (2007). Article  PubMed  PubMed Central  CAS  Google Scholar  * Salaun, B. et al. Differentiation associated regulation of microRNA expression _in vivo_ in human CD8+ T cell subsets.

_J. Transl. Med._ 9, 44 (2011). Article  CAS  PubMed  PubMed Central  Google Scholar  * Ranganathan, P. et al. Regulation of acute graft-versus-host disease by microRNA-155. _Blood_ 119,

4786–4797 (2012). Article  CAS  PubMed  PubMed Central  Google Scholar  * Fearon, D. T., Manders, P. & Wagner, S. D. Arrested differentiation, the self-renewing memory lymphocyte, and

vaccination. _Science_ 293, 248–250 (2001). THIS PERSPECTIVE ARTICLE IS THE FIRST TO DRAW A PARALLEL BETWEEN STEM CELLS AND MEMORY B AND T LYMPHOCYTES. Article  CAS  PubMed  Google Scholar 

* Stemberger, C. et al. Stem cell-like plasticity of naive and distinct memory CD8+ T cell subsets. _Semin. Immunol._ 21, 62–68 (2009). Article  CAS  PubMed  Google Scholar  * Luckey, C. J.

et al. Memory T and memory B cells share a transcriptional program of self-renewal with long-term hematopoietic stem cells. _Proc. Natl Acad. Sci. USA_ 103, 3304–3309 (2006). THIS PAPER

DESCRIBES A COMMON TRANSCRIPTIONAL SIGNATURE SHARED BETWEEN MEMORY T CELLS, MEMORY B CELLS AND LONG-TERM HAEMATOPOIETIC STEM CELLS, PROVIDING SYSTEMS BIOLOGY EVIDENCE FOR FEARON'S

HYPOTHESIS. Article  CAS  PubMed  PubMed Central  Google Scholar  * Knoblich, J. A. Mechanisms of asymmetric stem cell division. _Cell_ 132, 583–597 (2008). Article  CAS  PubMed  Google

Scholar  * Chang, J. T. et al. Asymmetric T lymphocyte division in the initiation of adaptive immune responses. _Science_ 315, 1687–1691 (2007). THIS PAPER PROVIDES THE FIRST EVIDENCE THAT

ASYMMETRIC CELL DIVISION CAN OCCUR IN MATURE T CELLS TO CONFER MEMORY AND EFFECTOR CELL FATES TO DAUGHTER CELLS. Article  CAS  PubMed  Google Scholar  * Barnett, B. E. et al. Asymmetric B

cell division in the germinal center reaction. _Science_ 335, 342–344 (2012). Article  CAS  PubMed  Google Scholar  * Ciocca, M. L., Barnett, B. E., Burkhardt, J. K., Chang, J. T. &

Reiner, S. L. Cutting edge: asymmetric memory T cell division in response to rechallenge. _J. Immunol._ 188, 4145–4148 (2012). Article  CAS  PubMed  Google Scholar  * Kalia, V. et al.

Prolonged interleukin-2Rα expression on virus-specific CD8+ T cells favors terminal-effector differentiation _in vivo_. _Immunity_ 32, 91–103 (2010). Article  CAS  PubMed  Google Scholar  *

Joshi, N. S. et al. Inflammation directs memory precursor and short-lived effector CD8+ T cell fates via the graded expression of T-BET transcription factor. _Immunity_ 27, 281–295 (2007).

Article  CAS  PubMed  PubMed Central  Google Scholar  * Morrison, S. J., Prowse, K. R., Ho, P. & Weissman, I. L. Telomerase activity in hematopoietic cells is associated with

self-renewal potential. _Immunity_ 5, 207–216 (1996). Article  CAS  PubMed  Google Scholar  * Hodes, R. J., Hathcock, K. S. & Weng, N. P. Telomeres in T and B cells. _Nature Rev.

Immunol._ 2, 699–706 (2002). Article  CAS  Google Scholar  * Sallusto, F. & Lanzavecchia, A. Memory in disguise. _Nature Med._ 17, 1182–1183 (2011). Article  CAS  PubMed  Google Scholar

  * Zhang, Y., Joe, G., Hexner, E., Zhu, J. & Emerson, S. G. Host-reactive CD8+ memory stem cells in graft-versus-host disease. _Nature Med._ 11, 1299–1305 (2005). THIS PAPER DESCRIBES A

MEMORY STEM CELL-LIKE CD8+ T CELL POPULATION IN A MOUSE MODEL OF GRAFT-VERSUS-HOST DISEASE. Article  CAS  PubMed  Google Scholar  * Gattinoni, L. et al. Wnt signaling arrests effector T

cell differentiation and generates CD8+ memory stem cells. _Nature Med._ 15, 808–813 (2009). Article  CAS  PubMed  Google Scholar  * Lugli, E., Gattinoni, L., Restifo, N. P. & Roederer,

M. The role of T memory stem cells: pathogenesis and vaccines. _J. Acquir. Immune Defic. Syndr._ 59, 59 (2012). Article  Google Scholar  * Papagno, L. et al. Immune activation and CD8+

T-cell differentiation towards senescence in HIV-1 infection. _PLoS. Biol._ 2, e20 (2004). Article  PubMed  PubMed Central  CAS  Google Scholar  * Chang, H. H., Hemberg, M., Barahona, M.,

Ingber, D. E. & Huang, S. Transcriptome-wide noise controls lineage choice in mammalian progenitor cells. _Nature_ 453, 544–547 (2008). Article  CAS  PubMed  PubMed Central  Google

Scholar  * Morrison, S. J. & Spradling, A. C. Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. _Cell_ 132, 598–611 (2008). Article  CAS  PubMed 

PubMed Central  Google Scholar  * Eckfeldt, C. E., Mendenhall, E. M. & Verfaillie, C. M. The molecular repertoire of the 'almighty' stem cell. _Nature Rev. Mol. Cell. Biol._ 6,

726–737 (2005). Article  CAS  Google Scholar  * Williams, R. L. et al. Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. _Nature_ 336,

684–687 (1988). Article  CAS  PubMed  Google Scholar  * Niwa, H., Burdon, T., Chambers, I. & Smith, A. Self-renewal of pluripotent embryonic stem cells is mediated via activation of

STAT3. _Genes Dev._ 12, 2048–2060 (1998). Article  CAS  PubMed  PubMed Central  Google Scholar  * Matsuda, T. et al. STAT3 activation is sufficient to maintain an undifferentiated state of

mouse embryonic stem cells. _EMBO J._ 18, 4261–4269 (1999). Article  CAS  PubMed  PubMed Central  Google Scholar  * Hall, J. et al. Oct4 and LIF/Stat3 additively induce Kruppel factors to

sustain embryonic stem cell self-renewal. _Cell Stem Cell_ 5, 597–609 (2009). Article  CAS  PubMed  Google Scholar  * Burdon, T., Stracey, C., Chambers, I., Nichols, J. & Smith, A.

Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells. _Dev. Biol._ 210, 30–43 (1999). Article  CAS  PubMed  Google Scholar  * Qu, C. K. & Feng, G.

S. Shp-2 has a positive regulatory role in ES cell differentiation and proliferation. _Oncogene_ 17, 433–439 (1998). Article  CAS  PubMed  Google Scholar  * Li, Z. et al. BMP4 Signaling Acts

via dual-specificity phosphatase 9 to control ERK activity in mouse embryonic stem cells. _Cell Stem Cell_ 10, 171–182 (2012). Article  CAS  PubMed  Google Scholar  * Ying, Q. L., Nichols,

J., Chambers, I. & Smith, A. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. _Cell_ 115, 281–292

(2003). Article  CAS  PubMed  Google Scholar  * Alarcon, C. et al. Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-β pathways. _Cell_ 139, 757–769 (2009).

Article  CAS  PubMed  PubMed Central  Google Scholar  * Lian, I. et al. The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation. _Genes Dev._ 24,

1106–1118 (2010). Article  CAS  PubMed  PubMed Central  Google Scholar  * Tamm, C., Bower, N. & Anneren, C. Regulation of mouse embryonic stem cell self-renewal by a Yes-YAP-TEAD2

signaling pathway downstream of LIF. _J. Cell Sci._ 124, 1136–1144 (2011). Article  PubMed  Google Scholar  * Leonard, W. J. & Spolski, R. Interleukin-21: a modulator of lymphoid

proliferation, apoptosis and differentiation. _Nature Rev. Immunol._ 5, 688–698 (2005). Article  CAS  Google Scholar  * Hinrichs, C. S. et al. IL-2 and IL-21 confer opposing differentiation

programs to CD8+ T cells for adoptive immunotherapy. _Blood_ 111, 5326–5333 (2008). Article  CAS  PubMed  PubMed Central  Google Scholar  * Yi, J. S., Du, M. & Zajac, A. J. A vital role

for interleukin-21 in the control of a chronic viral infection. _Science_ 324, 1572–1576 (2009). Article  CAS  PubMed  PubMed Central  Google Scholar  * Frohlich, A. et al. IL-21R on T cells

is critical for sustained functionality and control of chronic viral infection. _Science_ 324, 1576–1580 (2009). Article  CAS  PubMed  Google Scholar  * Yi, J. S., Ingram, J. T. &

Zajac, A. J. IL-21 deficiency influences CD8 T cell quality and recall responses following an acute viral infection. _J. Immunol._ 185, 4835–4845 (2010). Article  CAS  PubMed  Google Scholar

  * Cui, W., Liu, Y., Weinstein, J. S., Craft, J. & Kaech, S. M. An interleukin-21-interleukin-10-STAT3 pathway is critical for functional maturation of memory CD8+ T cells. _Immunity_

35, 792–805 (2011). Article  CAS  PubMed  PubMed Central  Google Scholar  * Wirth, T. C. et al. Repetitive antigen stimulation induces stepwise transcriptome diversification but preserves a

core signature of memory CD8+ T cell differentiation. _Immunity_ 33, 128–140 (2010). Article  CAS  PubMed  PubMed Central  Google Scholar  * Betz, U. A. & Muller, W. Regulated expression

of gp130 and IL-6 receptor α chain in T cell maturation and activation. _Int. Immunol._ 10, 1175–1184 (1998). Article  CAS  PubMed  Google Scholar  * Castellino, F. & Germain, R. N.

Chemokine-guided CD4+ T cell help enhances generation of IL-6RαhighIL-7Rα high prememory CD8+ T cells. _J. Immunol._ 178, 778–787 (2007). Article  CAS  PubMed  Google Scholar  * Siegel, A.

M. et al. A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory. _Immunity_ 35, 806–818 (2011). TOGETHER WITH REFERENCE 74, THIS

PAPER IDENTIFIES STAT3 AS A KEY TRANSCRIPTION FACTOR REQUIRED FOR THE FORMATION AND MAINTENANCE OF T CELL MEMORY IN MICE AND HUMANS. Article  CAS  PubMed  PubMed Central  Google Scholar  *

Yamada, T., Park, C. S., Mamonkin, M. & Lacorazza, H. D. Transcription factor ELF4 controls the proliferation and homing of CD8+ T cells via the Kruppel-like factors KLF4 and KLF2.

_Nature Immunol._ 10, 618–626 (2009). Article  CAS  Google Scholar  * Weinreich, M. A. et al. KLF2 transcription-factor deficiency in T cells results in unrestrained cytokine production and

upregulation of bystander chemokine receptors. _Immunity_ 31, 122–130 (2009). Article  CAS  PubMed  PubMed Central  Google Scholar  * Ji, Y. et al. Repression of the DNA-binding inhibitor

Id3 by Blimp-1 limits the formation of memory CD8+ T cells. _Nature Immunol._ 12, 1230–1237 (2011). Article  CAS  Google Scholar  * Yang, C. Y. et al. The transcriptional regulators Id2 and

Id3 control the formation of distinct memory CD8+ T cell subsets. _Nature Immunol._ 12, 1221–1229 (2011). REFERENCES 81 AND 82 SHOW THAT THE DNA-BINDING INHIBITOR ID3 IS CRUCIAL FOR THE

FORMATION OF LONG-LIVED MEMORY. Article  CAS  Google Scholar  * D'Cruz, L. M., Lind, K. C., Wu, B. B., Fujimoto, J. K. & Goldrath, A. W. Loss of E protein transcription factors E2A

and HEB delays memory-precursor formation during the CD8+ T-cell immune response. _Eur. J Immunol._ 42, 2031–2041 (2012). Article  CAS  PubMed  PubMed Central  Google Scholar  *

Thaventhiran, J. E. et al. Activation of the Hippo pathway by CTLA-4 regulates the expression of Blimp-1 in the CD8+ T cell. _Proc. Natl Acad. Sci. USA_ 27 Jun 2012

(doi:10.1073/pnas.1209115109). * Muranski, P. et al. Th17 cells are long lived and retain a stem cell-like molecular signature. _Immunity_ 35, 972–985 (2011). Article  CAS  PubMed  PubMed

Central  Google Scholar  * Luckey, C. J. & Weaver, C. T. Stem-cell-like qualities of immune memory; CD4+ T cells join the party. _Cell Stem Cell_ 10, 107–108 (2012). Article  CAS  PubMed

  PubMed Central  Google Scholar  * Kryczek, I. et al. Human TH17 cells are long-lived effector memory cells. _Sci. Transl. Med._ 3, 104ra100 (2011). THIS PAPER, ALONG WITH REFERENCE 85,

PROVIDES EVIDENCE THAT T H 17 CELLS ARE A LONG-LIVED MEMORY T CELL POPULATION THAT RETAIN STEM CELL-LIKE ATTRIBUTES IN MICE AND HUMANS. Article  PubMed  PubMed Central  CAS  Google Scholar 

* Wray, J. & Hartmann, C. WNTing embryonic stem cells. _Trends Cell Biol._ 22, 159–168 (2012). Article  CAS  PubMed  Google Scholar  * ten, B. D. et al. Embryonic stem cells require Wnt

proteins to prevent differentiation to epiblast stem cells. _Nature Cell Biol._ 13, 1070–1075 (2011). Article  CAS  Google Scholar  * Sato, N., Meijer, L., Skaltsounis, L., Greengard, P.

& Brivanlou, A. H. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. _Nature Med._

10, 55–63 (2004). Article  CAS  PubMed  Google Scholar  * Kielman, M. F. et al. Apc modulates embryonic stem-cell differentiation by controlling the dosage of β-catenin signaling. _Nature

Genet._ 32, 594–605 (2002). Article  CAS  PubMed  Google Scholar  * Doble, B. W., Patel, S., Wood, G. A., Kockeritz, L. K. & Woodgett, J. R. Functional redundancy of GSK-3α and GSK-3β in

Wnt/β-catenin signaling shown by using an allelic series of embryonic stem cell lines. _Dev. Cell_ 12, 957–971 (2007). Article  CAS  PubMed  PubMed Central  Google Scholar  * Wray, J. et

al. Inhibition of glycogen synthase kinase-3 alleviates Tcf3 repression of the pluripotency network and increases embryonic stem cell resistance to differentiation. _Nature Cell Biol._ 13,

838–845 (2011). Article  CAS  PubMed  Google Scholar  * Yi, F. et al. Opposing effects of Tcf3 and Tcf1 control Wnt stimulation of embryonic stem cell self-renewal. _Nature Cell Biol._ 13,

762–770 (2011). Article  CAS  PubMed  Google Scholar  * Clevers, H. Wnt/β-catenin signaling in development and disease. _Cell_ 127, 469–480 (2006). Article  CAS  PubMed  Google Scholar  *

Jeannet, G. et al. Long-term, multilineage hematopoiesis occurs in the combined absence of β-catenin and γ-catenin. _Blood_ 111, 142–149 (2008). Article  CAS  PubMed  Google Scholar  *

Willinger, T. et al. Human naive CD8 T cells down-regulate expression of the WNT pathway transcription factors lymphoid enhancer binding factor 1 and transcription factor 7 (T cell factor-1)

following antigen encounter in vitro and _in vivo_. _J. Immunol._ 176, 1439–1446 (2006). Article  CAS  PubMed  Google Scholar  * Gattinoni, L., Ji, Y. & Restifo, N. P. Wnt/β-catenin

signaling in T-cell immunity and cancer immunotherapy. _Clin. Cancer Res._ 16, 4695–4701 (2010). Article  CAS  PubMed  PubMed Central  Google Scholar  * Xue, H. H. & Zhao, D. M.

Regulation of mature T cell responses by the Wnt signaling pathway. _Ann. NY Acad. Sci._ 1247, 16–33 (2012). Article  CAS  PubMed  Google Scholar  * Gattinoni, L. Ji, Y. & Restifo, N. P.

β-catenin does not regulate memory T cell phenotype Reply. _Nature Med._ 16, 514–515 (2010). Article  CAS  Google Scholar  * Muralidharan, S. et al. Activation of Wnt signaling arrests

effector differentiation in human peripheral and cord blood-derived T lymphocytes. _J. Immunol._ 187, 5221–5232 (2011). Article  CAS  PubMed  Google Scholar  * Driessens, G. et al. β-catenin

inhibits T cell activation by selective interference with linker for activation of T cells-phospholipase C-γ1 phosphorylation. _J. Immunol._ 186, 784–790 (2011). Article  CAS  PubMed 

Google Scholar  * Zhao, D. M. et al. Constitutive activation of Wnt signaling favors generation of memory CD8 T cells. _J. Immunol._ 184, 1191–1199 (2010). Article  CAS  PubMed  Google

Scholar  * Jeannet, G. et al. Essential role of the Wnt pathway effector Tcf-1 for the establishment of functional CD8 T cell memory. _Proc. Natl Acad. Sci. USA_ 107, 9777–9782 (2010).

Article  CAS  PubMed  PubMed Central  Google Scholar  * Zhou, X. et al. Differentiation and persistence of memory CD8+ T cells depend on T cell factor 1. _Immunity_ 33, 229–240 (2010).

REFERENCES 104 AND 105 SHOW THAT TCF1–Β-CATENIN SIGNALLING IS ESSENTIAL FOR THE ESTABLISHMENT AND MAINTENANCE OF FUNCTIONAL CD8+ T CELL MEMORY. Article  CAS  PubMed  PubMed Central  Google

Scholar  * Driessens, G., Zheng, Y. & Gajewski, T. F. β-catenin does not regulate memory T cell phenotype. _Nature Med._ 16, 513–514 (2010). Article  CAS  PubMed  Google Scholar  *

Prlic, M. & Bevan, M. J. Cutting edge: β-catenin is dispensable for T cell effector differentiation, memory formation, and recall responses. _J. Immunol._ 187, 1542–1546 (2011). Article

  CAS  PubMed  Google Scholar  * Huelsken, J. & Held, W. Canonical Wnt signalling plays essential roles. _Eur. J. Immunol._ 39, 3582–3583 (2009). Article  CAS  PubMed  Google Scholar  *

Staal, F. J. & Sen, J. M. Canonical Wnt signalling plays essential roles. Author reply. _Eur. J. Immunol._ 39, 3583–3584 (2009). Article  CAS  Google Scholar  * Maeda, O. et al.

Plakoglobin (γ-catenin) has TCF/LEF family-dependent transcriptional activity in β-catenin-deficient cell line. _Oncogene_ 23, 964–972 (2004). Article  CAS  PubMed  Google Scholar  *

Murakami, M. et al. mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells. _Mol. Cell. Biol._ 24, 6710–6718 (2004). Article  CAS  PubMed  PubMed

Central  Google Scholar  * Sampath, P. et al. A hierarchical network controls protein translation during murine embryonic stem cell self-renewal and differentiation. _Cell Stem Cell_ 2,

448–460 (2008). Article  CAS  PubMed  Google Scholar  * Easley, C. A. et al. mTOR-mediated activation of p70 S6K induces differentiation of pluripotent human embryonic stem cells. _Cell

Reprogram._ 12, 263–273 (2010). Article  CAS  PubMed  PubMed Central  Google Scholar  * Araki, K. et al. mTOR regulates memory CD8 T-cell differentiation. _Nature_ 460, 108–112 (2009).

Article  CAS  PubMed  PubMed Central  Google Scholar  * Yang, K., Neale, G., Green, D. R., He, W. & Chi, H. The tumor suppressor Tsc1 enforces quiescence of naive T cells to promote

immune homeostasis and function. _Nature Immunol._ 12, 888–897 (2011). Article  CAS  Google Scholar  * Pearce, E. L. et al. Enhancing CD8 T-cell memory by modulating fatty acid metabolism.

_Nature_ 460, 103–107 (2009). TOGETHER WITH REFERENCE 114, THIS PAPER PROVIDES EVIDENCE THAT THE COMMITMENT OF A T CELL BETWEEN EFFECTOR OR MEMORY FATES IS REGULATED BY KEY,

PHARMACOLOGICALLY TARGETABLE, METABOLIC PATHWAYS. Article  CAS  PubMed  PubMed Central  Google Scholar  * Kim, E. H. et al. Signal integration by Akt regulates CD8 T cell effector and memory

differentiation. _J. Immunol._ 188, 4305–4314 (2012). Article  CAS  PubMed  Google Scholar  * Macintyre, A. N. et al. Protein kinase B controls transcriptional programs that direct

cytotoxic T cell fate but is dispensable for T cell metabolism. _Immunity_ 34, 224–236 (2011). Article  CAS  PubMed  PubMed Central  Google Scholar  * Hand, T. W. et al. Differential effects

of STAT5 and PI3K/AKT signaling on effector and memory CD8 T-cell survival. _Proc. Natl Acad. Sci. USA_ 107, 16601–16606 (2010). Article  CAS  PubMed  PubMed Central  Google Scholar  * Rao,

R. R., Li, Q., Odunsi, K. & Shrikant, P. A. The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-BET and

Eomesodermin. _Immunity_ 32, 67–78 (2010). Article  PubMed  PubMed Central  CAS  Google Scholar  * Rao, R. R., Li, Q., Gubbels Bupp, M. R. & Shrikant, P. A. Transcription factor foxo1

represses t-bet-mediated effector functions and promotes memory CD8+ T cell differentiation. _Immunity_ 36, 374–387 (2012). Article  CAS  PubMed  PubMed Central  Google Scholar  * Sinclair,

L. V. et al. Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking. _Nature Immunol._ 9, 513–521 (2008). Article  CAS  Google Scholar  *

Kerdiles, Y. M. et al. Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor. _Nature Immunol._ 10, 176–184 (2009). Article  CAS  Google

Scholar  * Tang, T. T. et al. The forkhead transcription factor AFX activates apoptosis by induction of the BCL-6 transcriptional repressor. _J. Biol. Chem._ 277, 14255–14265 (2002). Article

  CAS  PubMed  Google Scholar  * Zhang, X. et al. FOXO1 is an essential regulator of pluripotency in human embryonic stem cells. _Nature Cell Biol._ 13, 1092–1099 (2011). Article  CAS 

PubMed  Google Scholar  * Kolb, H. J. et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. _Blood_ 86, 2041–2050 (1995). CAS  PubMed  Google

Scholar  * Kochenderfer, J. N. et al. B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19

chimeric-antigen-receptor-transduced T cells. _Blood_ 119, 2709–2720 (2012). Article  CAS  PubMed  PubMed Central  Google Scholar  * Kalos, M. et al. T cells with chimeric antigen receptors

have potent antitumor effects and can establish memory in patients with advanced leukemia. _Sci. Transl. Med._ 3, 95ra73 (2011). Article  CAS  PubMed  PubMed Central  Google Scholar  *

Bollard, C. M. et al. Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer. _Blood_ 110, 2838–2845 (2007).

Article  CAS  PubMed  PubMed Central  Google Scholar  * Rosenberg, S. A. et al. Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer

immunotherapy. _Clin. Cancer Res._ 17, 4550–4557 (2011). Article  CAS  PubMed  PubMed Central  Google Scholar  * Robbins, P. F. et al. Tumor regression in patients with metastatic synovial

cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1. _J. Clin. Oncol._ 29, 917–924 (2011). Article  PubMed  PubMed Central  Google Scholar  * Klebanoff,

C. A., Khong, H. T., Antony, P. A., Palmer, D. C. & Restifo, N. P. Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy. _Trends

Immunol._ 26, 111–117 (2005). Article  CAS  PubMed  PubMed Central  Google Scholar  * Robbins, P. F. et al. Cutting edge: persistence of transferred lymphocyte clonotypes correlates with

cancer regression in patients receiving cell transfer therapy. _J. Immunol._ 173, 7125–7130 (2004). Article  CAS  PubMed  Google Scholar  * Pule, M. A. et al. Virus-specific T cells

engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma. _Nature Med._ 14, 1264–1270 (2008). Article  CAS  PubMed  Google

Scholar  * Zhou, J. et al. Telomere length of transferred lymphocytes correlates with _in vivo_ persistence and tumor regression in melanoma patients receiving cell transfer therapy. _J.

Immunol._ 175, 7046–7052 (2005). Article  CAS  PubMed  Google Scholar  * Schwartzentruber, D. J. et al. In vitro predictors of therapeutic response in melanoma patients receiving

tumor-infiltrating lymphocytes and interleukin-2. _J. Clin. Oncol._ 12, 1475–1483 (1994). Article  CAS  PubMed  Google Scholar  * Besser, M. J. et al. Clinical responses in a phase II study

using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients. _Clin. Cancer Res._ 16, 2646–2655 (2010). Article  CAS  PubMed  Google Scholar

  * Louis, C. U. et al. Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma. _Blood_ 118, 6050–6056 (2011). Article  CAS 

PubMed  PubMed Central  Google Scholar  * Huang, J. et al. Modulation by IL-2 of CD70 and CD27 expression on CD8+ T cells: importance for the therapeutic effectiveness of cell transfer

immunotherapy. _J. Immunol._ 176, 7726–7735 (2006). Article  CAS  PubMed  Google Scholar  * Berger, C. et al. Adoptive transfer of effector CD8+ T cells derived from central memory cells

establishes persistent T cell memory in primates. _J. Clin. Invest._ 118, 294–305 (2008). Article  CAS  PubMed  Google Scholar  * Wang, X. et al. Engraftment of human central memory-derived

effector CD8+ T cells in immunodeficient mice. _Blood_ 117, 1888–1898 (2011). Article  CAS  PubMed  PubMed Central  Google Scholar  * Sussman, J. J., Parihar, R., Winstead, K. &

Finkelman, F. D. Prolonged culture of vaccine-primed lymphocytes results in decreased antitumor killing and change in cytokine secretion. _Cancer Res._ 64, 9124–9130 (2004). Article  CAS 

PubMed  Google Scholar  * Gattinoni, L. et al. Acquisition of full effector function in vitro paradoxically impairs the _in vivo_ antitumor efficacy of adoptively transferred CD8+ T cells.

_J. Clin. Invest._ 115, 1616–1626 (2005). THIS PAPER IS THE FIRST TO CONCEPTUALIZE AND PROVIDE EXPERIMENTAL EVIDENCE DEMONSTRATING THE DETRIMENTAL EFFECT OF T CELL DIFFERENTIATION ON THE

ANTITUMOUR ACTIVITY OF CD8+ T LYMPHOCYTES USED FOR ADOPTIVE T CELL-BASED THERAPY. Article  CAS  PubMed  PubMed Central  Google Scholar  * Klebanoff, C. A. et al. Central memory

self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells. _Proc. Natl Acad. Sci. USA_ 102, 9571–9576 (2005). Article  CAS  PubMed  PubMed

Central  Google Scholar  * Le, H. K. et al. Incubation of antigen-sensitized T lymphocytes activated with bryostatin 1 + ionomycin in IL-7 + IL-15 increases yield of cells capable of

inducing regression of melanoma metastases compared to culture in IL-2. _Cancer Immunol. Immunother._ 58, 1565–1576 (2009). Article  CAS  PubMed  PubMed Central  Google Scholar  * Stark, F.

C., Sad, S. & Krishnan, L. Intracellular bacterial vectors that induce CD8(+) T cells with similar cytolytic abilities but disparate memory phenotypes provide contrasting tumor

protection. _Cancer Res._ 69, 4327–4334 (2009). Article  CAS  PubMed  Google Scholar  * Klebanoff, C. A. et al. Determinants of successful CD8+ T-cell adoptive immunotherapy for large

established tumors in mice. _Clin. Cancer Res._ 17, 5343–5352 (2011). Article  CAS  PubMed  PubMed Central  Google Scholar  * Topalian, S. L., Muul, L. M., Solomon, D. & Rosenberg, S. A.

Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials. _J. Immunol. Methods_ 102, 127–141 (1987). Article  CAS  PubMed  Google Scholar  * Riddell, S. R. et al.

Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. _Science_ 257, 238–241 (1992). Article  CAS  PubMed  Google Scholar  * Gattinoni, L.,

Powell, D. J. Jr, Rosenberg, S. A. & Restifo, N. P. Adoptive immunotherapy for cancer: building on success. _Nature Rev. Immunol._ 6, 383–393 (2006). Article  CAS  Google Scholar  *

Gattinoni, L., Klebanoff, C. A. & Restifo, N. P. Pharmacologic induction of CD8+ T cell memory: better living through chemistry. _Sci. Transl. Med._ 1, 11ps12 (2009). Article  PubMed 

PubMed Central  Google Scholar  * Manjunath, N. et al. Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes. _J. Clin. Invest._ 108, 871–878 (2001).

Article  CAS  PubMed  PubMed Central  Google Scholar  * van der Windt, G. J. et al. Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. _Immunity_

36, 68–78 (2012). Article  CAS  PubMed  Google Scholar  * Butler, M. O. et al. Establishment of antitumor memory in humans using in vitro-educated CD8+ T cells. _Sci. Transl. Med._ 3, 80ra34

(2011). Article  PubMed  CAS  Google Scholar  * Zeng, R. et al. Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function. _J. Exp. Med._ 201, 139–148 (2005). Article  CAS

  PubMed  PubMed Central  Google Scholar  * Li, Y., Bleakley, M. & Yee, C. IL-21 influences the frequency, phenotype, and affinity of the antigen-specific CD8 T cell response. _J.

Immunol._ 175, 2261–2269 (2005). Article  CAS  PubMed  Google Scholar  * Albrecht, J. et al. IL-21-treated naive CD45RA+ CD8+ T cells represent a reliable source for producing

leukemia-reactive cytotoxic T lymphocytes with high proliferative potential and early differentiation phenotype. _Cancer Immunol. Immunother._ 60, 235–248 (2011). Article  CAS  PubMed 

Google Scholar  * Pearce, E. L. Metabolism in T cell activation and differentiation. _Curr. Opin. Immunol._ 22, 314–320 (2010). Article  CAS  PubMed  PubMed Central  Google Scholar  *

Aberle, H. Bauer, A., Stappert, J., Kispert, A. & Kemler, R. β-catenin is a target for the ubiquitin-proteasome pathway. _EMBO J._ 16, 3797–3804 (1997). Article  CAS  PubMed  PubMed

Central  Google Scholar  * Chi, H. Regulation and function of mTOR signalling in T cell fate decisions. _Nature Rev. Immunol._ 12, 325–338 (2012). Article  CAS  Google Scholar  * Cohen, P.

& Goedert, M. GSK3 inhibitors: development and therapeutic potential. _Nature Rev. Drug Discov._ 3, 479–487 (2004). Article  CAS  Google Scholar  * Zippelius, A. et al. Effector function

of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance. _Cancer Res._ 64, 2865–2873 (2004). Article  CAS  PubMed  Google Scholar  * Ahmadzadeh, M. et

al. Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired. _Blood_ 114, 1537–1544 (2009). Article  CAS  PubMed  PubMed Central

  Google Scholar  * Baitsch, L. et al. Exhaustion of tumor-specific CD8 T cells in metastases from melanoma patients. _J. Clin. Invest._ 121, 2350–2360 (2011). Article  CAS  PubMed  PubMed

Central  Google Scholar  * Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. _Cell_ 126, 663–676

(2006). Article  CAS  PubMed  Google Scholar  * Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. _Cell_ 131, 861–872 (2007).

REFERENCES 165 AND 166 PROVIDE EVIDENCE IN MICE AND HUMANS THAT A PLURIPOTENT STEM CELL CAN BE ARTIFICIALLY DERIVED FROM AN ADULT SOMATIC CELL BY FORCED EXPRESSION OF A LIMITED NUMBER OF KEY

TRANSCRIPTION FACTORS. Article  CAS  PubMed  Google Scholar  * Anokye-Danso, F. et al. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. _Cell

Stem Cell_ 8, 376–388 (2011). THIS PAPER SHOWS THAT A SINGLE MICRORNA CLUSTER (MICRORNA 302–367) CAN EFFICIENTLY REPROGRAMME ADULT SOMATIC CELLS TO ACQUIRE PLURIPOTENCY. Article  CAS  PubMed

  PubMed Central  Google Scholar  * Eminli, S. et al. Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. _Nature Genet._

41, 968–976 (2009). Article  CAS  PubMed  Google Scholar  * Loh, Y. H. et al. Reprogramming of T cells from human peripheral blood. _Cell Stem Cell_ 7, 15–19 (2010). Article  PubMed  PubMed

Central  Google Scholar  * Staerk, J. et al. Reprogramming of human peripheral blood cells to induced pluripotent stem cells. _Cell Stem Cell_ 7, 20–24 (2010). Article  CAS  PubMed  PubMed

Central  Google Scholar  * Seki, T. et al. Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. _Cell Stem Cell_ 7, 11–14 (2010). Article 

CAS  PubMed  Google Scholar  * Schmitt, T. M. et al. Induction of T cell development and establishment of T cell competence from embryonic stem cells differentiated in vitro. _Nature

Immunol._ 5, 410–417 (2004). Article  CAS  Google Scholar  * Schmitt, T. M. & Zuniga-Pflucker, J. C. Induction of T cell development from hematopoietic progenitor cells by delta-like-1

in vitro. _Immunity_ 17, 749–756 (2002). THIS PAPER DESCRIBES A SIMPLE _IN VITRO_ CULTURE SYSTEM THAT ALLOWS FOR THE GENERATION OF MATURE T CELLS FROM HAEMATOPOIETIC PROGENITORS. Article 

CAS  PubMed  Google Scholar  * Clark, R. A., Yamanaka, K., Bai, M., Dowgiert, R. & Kupper, T. S. Human skin cells support thymus-independent T cell development. _J. Clin. Invest._ 115,

3239–3249 (2005). Article  CAS  PubMed  PubMed Central  Google Scholar  * Zhao, Y. et al. Extrathymic generation of tumor-specific T cells from genetically engineered human hematopoietic

stem cells via Notch signaling. _Cancer Res._ 67, 2425–2429 (2007). Article  CAS  PubMed  PubMed Central  Google Scholar  * Lei, F., Haque, R., Weiler, L., Vrana, K. E. & Song, J. T

lineage differentiation from induced pluripotent stem cells. _Cell. Immunol._ 260, 1–5 (2009). Article  CAS  PubMed  Google Scholar  * Vierbuchen, T. et al. Direct conversion of fibroblasts

to functional neurons by defined factors. _Nature_ 463, 1035–1041 (2010). Article  CAS  PubMed  PubMed Central  Google Scholar  * Marro, S. et al. Direct lineage conversion of terminally

differentiated hepatocytes to functional neurons. _Cell Stem Cell_ 9, 374–382 (2011). Article  CAS  PubMed  PubMed Central  Google Scholar  * Ieda, M. et al. Direct reprogramming of

fibroblasts into functional cardiomyocytes by defined factors. _Cell_ 142, 375–386 (2010). Article  CAS  PubMed  PubMed Central  Google Scholar  * Szabo, E. et al. Direct conversion of human

fibroblasts to multilineage blood progenitors. _Nature_ 468, 521–526 (2010). Article  CAS  PubMed  Google Scholar  * Sekiya, S. & Suzuki, A. Direct conversion of mouse fibroblasts to

hepatocyte-like cells by defined factors. _Nature_ 475, 390–393 (2011). Article  CAS  PubMed  Google Scholar  * Miura, K. et al. Variation in the safety of induced pluripotent stem cell

lines. _Nature Biotechnol._ 27, 743–745 (2009). Article  CAS  Google Scholar  * Bonini, C. et al. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia.

_Science_ 276, 1719–1724 (1997). Article  CAS  PubMed  Google Scholar  * Di, S. A. et al. Inducible apoptosis as a safety switch for adoptive cell therapy. _N. Engl. J. Med._ 365, 1673–1683

(2011). Article  Google Scholar  * Wu, S. M. & Hochedlinger, K. Harnessing the potential of induced pluripotent stem cells for regenerative medicine. _Nature Cell Biol._ 13, 497–505

(2011). Article  CAS  PubMed  Google Scholar  * Zhao, T., Zhang, Z. N., Rong, Z. & Xu, Y. Immunogenicity of induced pluripotent stem cells. _Nature_ 474, 212–215 (2011). Article  CAS 

PubMed  Google Scholar  * Wherry, E. J. et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. _Nature Immunol._ 4, 225–234 (2003). Article  CAS  Google Scholar  *

Chang, J. T. et al. Asymmetric proteasome segregation as a mechanism for unequal partitioning of the transcription factor T-bet during T lymphocyte division. _Immunity_ 34, 492–504 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar  * Appay, V. et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. _Nature Med._ 8,

379–385 (2002). Article  CAS  PubMed  Google Scholar  * Willinger, T., Freeman, T., Hasegawa, H., McMichael, A. J. & Callan, M. F. Molecular signatures distinguish human central memory

from effector memory CD8 T cell subsets. _J. Immunol._ 175, 5895–5903 (2005). Article  CAS  PubMed  Google Scholar  * Holmes, S., He, M., Xu, T. & Lee, P. P. Memory T cells have gene

expression patterns intermediate between naive and effector. _Proc. Natl Acad. Sci. USA_ 102, 5519–5523 (2005). Article  CAS  PubMed  PubMed Central  Google Scholar  * Waddington, C. H. _The

Strategy of the Genes_ (George Allen & Unwin, 1957). Google Scholar  * Chapuis, A. G. et al. Transferred melanoma-specific CD8+ T cells persist, mediate tumor regression, and acquire

central memory phenotype. _Proc. Natl Acad. Sci. USA_ 109, 4592–4597 (2012). Article  CAS  PubMed  PubMed Central  Google Scholar  * Swain, S. L., McKinstry, K. K. & Strutt, T. M.

Expanding roles for CD4+ T cells in immunity to viruses. _Nature Rev. Immunol._ 12, 136–148 (2012). Article  CAS  Google Scholar  * Pepper, M. et al. Different routes of bacterial infection

induce long-lived TH1 memory cells and short-lived TH17 cells. _Nature Immunol._ 11, 83–89 (2010). Article  CAS  Google Scholar  * Luthje, K. et al. The development and fate of follicular

helper T cells defined by an IL-21 reporter mouse. _Nature Immunol._ 13, 491–498 (2012). Article  CAS  Google Scholar  * Nurieva, R. I. et al. Generation of T follicular helper cells is

mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. _Immunity_ 29, 138–149 (2008). Article  CAS  PubMed  PubMed Central  Google Scholar  Download references

ACKNOWLEDGEMENTS This work was supported by the National Institutes of Health, Center for Regenerative Medicine (NIH-CRM) and by the Center for Cancer Research (CCR) by the US National

Cancer Institute (Bethesda, Maryland). The authors would like to thank M. Rao for helpful discussions about regenerative medicine. M. Bachinski copyedited the manuscript during construction.

J. Crompton, R. Roychoudhuri, P. Muranski, D. Palmer, Y. Ji, M. Sukumar, J. Pan, A. Leonardi, Z. Franco, Z. Yu and D. Clever provided a lively sounding board for concepts presented here. J.

C. Yang, U. S. Kammula, R. A. Morgan, S. A. Feldman, P. F. Robbins, R. M. Sherry, M. Parkhurst, M. Hughes and G. Phan made many valuable suggestions regarding the clinical translation of

the work described. The authors would especially like to thank our longtime stalwart ally in all of these efforts S. A. Rosenberg. AUTHOR INFORMATION Author notes * Luca Gattinoni and

Christopher A. Klebanoff: These authors contributed equally to this work. AUTHORS AND AFFILIATIONS * Center for Cancer Research, National Cancer Institute, National Institutes of Health,

Bethesda, 20892, Maryland, USA Luca Gattinoni, Christopher A. Klebanoff & Nicholas P. Restifo Authors * Luca Gattinoni View author publications You can also search for this author

inPubMed Google Scholar * Christopher A. Klebanoff View author publications You can also search for this author inPubMed Google Scholar * Nicholas P. Restifo View author publications You can

also search for this author inPubMed Google Scholar CORRESPONDING AUTHORS Correspondence to Luca Gattinoni or Nicholas P. Restifo. ETHICS DECLARATIONS COMPETING INTERESTS The authors

declare no competing financial interests. RELATED LINKS FURTHER INFORMATION Luca Gattinoni's homepage Nicholas P. Restifo's homepage GLOSSARY * Self-renewal A biological process by

which a cell gives rise to one or two daughter cells that have a developmental potential that is indistinguishable from that of the mother cell. * Multipotency The potential for a cell to

give rise to progeny with the capacity to form multiple, but not all possible, lineages. * Tumour-infiltrating lymphocytes (TILs). The heterogeneous population of T cells found in a tumour

bed. These cells are characterized by a diversity of phenotypes, antigen specificities, avidities and functional characteristics. They can be activated and expanded _ex vivo_ and re-infused

into a tumour-bearing host to mediate tumour regression. * Mass cytometry Also known as cytometry by time-of-flight (CyTOF). A platform that couples flow cytometry with mass spectrometry.

This technique enables the simultaneous evaluation of at least 45 simultaneous phenotypic and functional parameters on a single cell without the use of fluorescent agents or interference

from spectral overlap. * Senescence A biological process by which cells undergo growth arrest after extensive replication. * Homeostatic proliferation A process of activation and

proliferation of leukocytes in a lymphopaenic environment. T cell homeostatic proliferation is driven by T cell receptor interactions with self-peptide–MHC complexes and responsiveness to

homeostatic cytokines such as interleukin-7 (IL-7), IL-15 and possibly IL-21. * TCR excision circles (TRECs). Circular, stable extra-chromosomal DNA fragments that are generated during

recombination of variable (V), diversity (D) and joining regions (J) of the T cell receptor. TRECs do not replicate with cellular proliferation and are thus diluted with every cell division,

allowing the assessment of the replicative history of a T cell. * Asymmetric cell division A conserved mechanism by which a cell divides into daughter cells of unequal size and cytoplasmic

content, thus conferring differential developmental fates to progeny cells. * Telomere The segment at the end of chromosomal arms consisting of a series of repeated DNA sequences (TTAGGG in

all vertebrates) that regulates chromosomal replication at each cell division. * Stem cell niche A specialized microenvironment containing stem cells that supports their maintenance and

regulates their function. * Common γ-chain (γC). A signalling subunit common to the receptors for interleukin-2 (IL-2), IL-4, IL-7, IL-9, IL-15 and IL-21. * Exhaustion A state of T cell

dysfunction arising during reiterative antigen stimulations such as chronic infections and cancer. It is defined by poor effector function and proliferative response to antigenic stimuli,

expression of inhibitory receptors and a transcriptional state that is distinct from that of functional effector or memory T cells. * Autosomal-dominant hyper-IgE syndrome (AD-HIES). Also

known as Job's syndrome. A rare primary immunodeficiency characterized by recurrent skin abscesses, cyst-forming pneumonias and extreme increases of serum IgE levels. Most AD-HIES cases

are caused by dominant-negative mutations in _STAT3_. * Epigenetic modifications Heritable molecular alterations of the genome that do not involve changes to the nucleotide sequence that

regulates gene or microRNA expression. They include DNA methylation, histone modifications and nucleosome positioning. * Induced pluripotent stem (iPS) cells Pluripotent stem cells

artificially derived from non-pluripotent cells, such as an adult somatic cell by forced expression of specific genes or microRNAs. * Suicide genes Genes capable of selectively eliminating

the cells into which they have been transduced following the administration of a drug. RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Gattinoni, L.,

Klebanoff, C. & Restifo, N. Paths to stemness: building the ultimate antitumour T cell. _Nat Rev Cancer_ 12, 671–684 (2012). https://doi.org/10.1038/nrc3322 Download citation *

Published: 21 September 2012 * Issue Date: October 2012 * DOI: https://doi.org/10.1038/nrc3322 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content:

Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative